Recruitment

Recruitment Status
Terminated
Estimated Enrollment
12

Summary

Conditions
iPS Cell Manufacture and Banking
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other

Participation Requirements

Age
Between 18 years and 61 years
Gender
Both males and females

Description

This study is being done to produce a bank of iPS cells that researchers from around the world can use for many different purposes. Some examples of such uses include basic research, discovery of new medicines, developing new products and services useful for studying human disease, and developing ne...

This study is being done to produce a bank of iPS cells that researchers from around the world can use for many different purposes. Some examples of such uses include basic research, discovery of new medicines, developing new products and services useful for studying human disease, and developing new cell-based products useful for treating people that have diseases. The idea of using cells made from human iPS cells to treat human diseases is of great interest in medicine. In this bank, a single donor's cells could be used to treat many people. The iPS cells that are made as part of this study will be included in a bank owned by CDI. The iPS cells and the cells made from them will be available for laboratory research or for clinical use in patients. It is possible that the iPS cells made from the blood donated and cells made from the iPS cells could be beneficial to many different patients and be used for many different research projects to understand human biology and disease.

Tracking Information

NCT #
NCT03434808
Collaborators
Cellular Dynamics International, Inc. - A FUJIFILM Company
Investigators
Principal Investigator: Dennis Confer, MD National Marrow Donor Program Principal Investigator: Amanda Mack, PhD Cellular Dynamics International, Inc. - A FUJIFILM Company